Tomorrow Abbott will publish it's past quarters results. For this year the company, based in Abbott Park revenue will be around 39.29 billion USD. This is according to the average of the analysts' estimates. This is quite more than 2021's revenue of 34.61 billion USD.
The analysts expect for 2021 a net profit of 7.79 billion USD. The majority of the analysts expects for this year a profit per share of 4.36 USD. So the price/earnings-ratio equals 27.23.
Per share the analysts anticipate on a dividend of 1.66 USD per share. Abbott 's dividend yield thus equals 1.4 percent. The average dividend yield of the pharmaceutical companies equals a poor 1.39 percent.
Abbott 's market capitalization is based on the number of outstanding shares around 209.26 billion USD. 23
At 1.00 the stock trades 0 percent lower at 118.73 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.